Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Change in Accured Expenses of $2.4 million in Q4 2025, down 48.59% quarter-over-quarter from $4.7 million in Q3 2025, and down 35.5% on a YoY basis from $3.8 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- In Q4 2025, Change in Accured Expenses fell 35.5% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $9.0 million (up 317.72% YoY), while the FY2025 annual figure was $7.0 million, up 143.07% from the prior year.
- Change in Accured Expenses was $2.4 million for Q4 2025 at Prestige Consumer Healthcare, down from $4.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $18.4 million in Q2 2021 to a low of -$23.1 million in Q1 2021.
- Historically, Change in Accured Expenses has averaged -$283250.0 across 5 years, with a median of $830500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 379.42% in 2023, then plunged 453.98% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at -$9.5 million in 2021, then soared by 84.84% to -$1.4 million in 2022, then soared by 379.42% to $4.0 million in 2023, then fell by 6.37% to $3.8 million in 2024, then tumbled by 35.5% to $2.4 million in 2025.
- The last three Change in Accured Expenses figures came in at $2.4 million (Q4 2025), $4.7 million (Q3 2025), and -$813000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.44 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | -813,000.00 |
| Jun 30, 2025 | -813,000.00 |
| Mar 31, 2025 | 2.63 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Mar 31, 2024 | -8.49 Mn |
| Mar 31, 2024 | -8.49 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | -3.25 Mn |
| Sep 30, 2023 | -3.25 Mn |